Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
Trastuzumab containing regimens for early breast cancer
2012
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Very high quantitative tumor HER2 content and outcome in early breast cancer
2011
Hypoxia and intra-complex genetic suppressors rescue complex I mutants by a shared mechanism
2024 StandoutNobel
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
Parkinson disease
2017 Standout
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial
2019
Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's Disease
2010
Parkinson's disease
2021 Standout
Breast cancer
2016 Standout
The NLRP3 inflammasome in acute myocardial infarction
2017
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
2018
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
2014
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
2013
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
2010
The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
2018
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer
2013
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
Parkinson's disease
2015 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Endpoints in cancer clinical trials
2014
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
2015
Perspectives of mitochondrial medicine
2013
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
2017 Standout
Gender and non motor fluctuations in Parkinson's disease: A prospective study
2016
Non-motor features of Parkinson disease
2017 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations
2016
Levodopa/carbidopa/entacapone in Parkinson’s disease
2009
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Maftools: efficient and comprehensive analysis of somatic variants in cancer
2018 Standout
Biological Therapies of Immunologic Diseases
2017
Mitochondrial Diseases: Hope for the Future
2020
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
2014
De novo design of a homo-trimeric amantadine-binding protein
2019 StandoutNobel
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
2012
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
Therapeutic prospects for Parkinson disease
2013
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Levodopa-induced dyskinesia in Parkinson disease
2018
Metabolic control of cell death
2014 Science
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
2016
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease
2007
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
2018
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
2018
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
2017
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of Mika Leinonen being referenced
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
2009
The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
2014
Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease
2013
Effects of Idebenone on Color Vision in Patients With Leber Hereditary Optic Neuropathy
2012
Entacapone Increases Levodopa Exposure and Reduces Plasma Levodopa Variability When Used With Sinemet CR
2005
Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data
2009
Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson’s disease
2008
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
2019
Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
2016
Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease
2016
Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)
2012
A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy
2011
A randomized trial of inhaled levodopa (CVT‐301) for motor fluctuations in Parkinson's disease
2016
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
2011